Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2022-04-29

FDA Approved: LEVORA — Supplemental Application (Mayne Pharma Inc.)

View source ↗

Summary

The FDA approved a supplemental application for LEVORA (levonorgestrel and ethinyl estradiol) from Mayne Pharma, updating the product labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LEVORA (levonorgestrel and ethinyl estradiol)

Snippet

SUPPL AP for LEVORA (LEVONORGESTREL AND ETHINYL ESTRADIOL)